Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation

Research output: Contribution to journal › Letter

9 Scopus citations

Cite this

@article{35df98ef35094a3e9a4fc70ecfb70979,

title = "Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation",

author = "F. Khan and Linden, {Michael A} and Zantek, {Nicole D} and Vercellotti, {Gregory M}",

year = "2014",

month = jun,

doi = "10.1111/tme.12121",

language = "English (US)",

volume = "24",

pages = "187--188",

journal = "Transfusion Medicine",

issn = "0958-7578",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation

AU - Khan, F.

AU - Linden, Michael A

AU - Zantek, Nicole D

AU - Vercellotti, Gregory M

PY - 2014/6

Y1 - 2014/6

UR - http://www.scopus.com/inward/record.url?scp=84901489095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901489095&partnerID=8YFLogxK

U2 - 10.1111/tme.12121

DO - 10.1111/tme.12121

M3 - Letter

C2 - 24809981

AN - SCOPUS:84901489095

VL - 24

SP - 187

EP - 188

JO - Transfusion Medicine

JF - Transfusion Medicine

SN - 0958-7578

IS - 3

ER -